Cetera Investment Advisers
BIO icon

Cetera Investment Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cetera Investment Advisers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
7,149
-447
-6% -$127K ﹤0.01% 2348
2026
Q1 		$2.12M Buy
7,596
+48
+0.6% +$13.8K ﹤0.01% 2234
2025
Q4 		$2.29M Sell
7,548
-515
-6% -$161K ﹤0.01% 2095
2025
Q3 		$2.26M Buy
8,063
+5,871
+268% +$1.6M ﹤0.01% 2067
2025
Q2 		$529K Buy
2,192
+260
+13% +$61.5K ﹤0.01% 2924
2025
Q1 		$471K Buy
1,932
+215
+13% +$64.7K ﹤0.01% 2897
2024
Q4 		$564K Buy
1,717
+29
+2% +$9.84K ﹤0.01% 2585
2024
Q3 		$565K Sell
1,688
-327
-16% -$104K ﹤0.01% 2555
2024
Q2 		$550K Sell
2,015
-516
-20% -$150K ﹤0.01% 2514
2024
Q1 		$875K Buy
2,531
+1,030
+69% +$339K ﹤0.01% 2180
2023
Q4 		$485K Sell
1,501
-652
-30% -$204K ﹤0.01% 1508
2023
Q3 		$772K Buy
2,153
+594
+38% +$229K 0.01% 1180
2023
Q2 		$591K Sell
1,559
-104
-6% -$42.3K 0.01% 1354
2023
Q1 		$797K Sell
1,663
-20
-1% -$9.36K 0.01% 1149
2022
Q4 		$708K Buy
1,683
+245
+17% +$98.9K 0.01% 1174
2022
Q3 		$1K Buy
1,438
+667
+87% +$333K ﹤0.01% 1706
2022
Q2 		$382K Sell
771
-401
-34% -$209K 0.01% 1262
2022
Q1 		$660K Sell
1,172
-210
-15% -$127K 0.01% 997
2021
Q4 		$1.04M Buy
1,382
+328
+31% +$245K 0.02% 793
2021
Q3 		$786K Sell
1,054
-103
-9% -$77.2K 0.01% 877
2021
Q2 		$745K Buy
1,157
+285
+33% +$173K 0.01% 898
2021
Q1 		$498K Buy
872
+383
+78% +$227K 0.01% 981
2020
Q4 		$285K Buy
+489
New +$278K 0.01% 1262

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cetera Investment Advisers's BIO Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Bio-Rad Laboratories Class A (BIO) stake by 5.9% in Q2 2026, selling an estimated $127K and leaving 7,149 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

Cetera Investment Advisers first reported a position in BIO in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.29M in Q4 2025. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Cetera Investment Advisers held 7,149 shares of Bio-Rad Laboratories Class A worth $2.1M as of Q2 2026.
  • Cetera Investment Advisers sold 447 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $127K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2348 holding.
  • Cetera Investment Advisers first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's Bio-Rad Laboratories Class A position peaked at $2.29M in Q4 2025.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.